ATE179522T1 - Verfahren und mittel zum nachweis von krankheitszuständen aus änderungen im östrogenstoffwechsel - Google Patents

Verfahren und mittel zum nachweis von krankheitszuständen aus änderungen im östrogenstoffwechsel

Info

Publication number
ATE179522T1
ATE179522T1 AT90113694T AT90113694T ATE179522T1 AT E179522 T1 ATE179522 T1 AT E179522T1 AT 90113694 T AT90113694 T AT 90113694T AT 90113694 T AT90113694 T AT 90113694T AT E179522 T1 ATE179522 T1 AT E179522T1
Authority
AT
Austria
Prior art keywords
estrone
metabolites
enzymatic
quotient
estrogen
Prior art date
Application number
AT90113694T
Other languages
English (en)
Inventor
Jon J Michnovicz
Richard J Hershcopf
H Leon Bradlow
Jack Fishman
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE179522T1 publication Critical patent/ATE179522T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
AT90113694T 1989-07-17 1990-07-17 Verfahren und mittel zum nachweis von krankheitszuständen aus änderungen im östrogenstoffwechsel ATE179522T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38106489A 1989-07-17 1989-07-17
US54929090A 1990-07-11 1990-07-11

Publications (1)

Publication Number Publication Date
ATE179522T1 true ATE179522T1 (de) 1999-05-15

Family

ID=27009231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113694T ATE179522T1 (de) 1989-07-17 1990-07-17 Verfahren und mittel zum nachweis von krankheitszuständen aus änderungen im östrogenstoffwechsel

Country Status (6)

Country Link
EP (1) EP0409176B1 (de)
JP (1) JPH03215745A (de)
AT (1) ATE179522T1 (de)
AU (1) AU641409B2 (de)
CA (1) CA2021309C (de)
DE (1) DE69033072T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962242A (en) * 1995-09-19 1999-10-05 Immuna Care Corporation Methods of predicting estrogen-dependent osteopenia
US5854009A (en) * 1995-09-19 1998-12-29 Immuna Care Corporation Method of detecting estrogen-sensitive pathologies
CN113189334B (zh) * 2021-04-27 2022-04-26 华南农业大学 Comt蛋白在食蟹猴超数排卵良好应答预测中的应用
PL441360A1 (pl) * 2022-06-02 2023-12-04 Gdański Uniwersytet Medyczny Zastosowanie nadtlenku wodoru oraz 17β-estradiolu i jego metabolitów jako biomarkerów w sposobie diagnozowania in vitro chorób neurodegeneracyjnych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4711856A (en) * 1984-09-19 1987-12-08 Mayo Medical Resources Nuclear binding assay for steroid receptor functionality in cancerous cells
EP0200960A1 (de) * 1985-05-08 1986-11-12 Abbott Laboratories Fluoreszenzpolarisationsimmunoassay auf Gesamtöstriol

Also Published As

Publication number Publication date
AU5905190A (en) 1991-01-17
EP0409176A3 (en) 1991-10-30
CA2021309A1 (en) 1991-01-18
AU641409B2 (en) 1993-09-23
EP0409176B1 (de) 1999-04-28
DE69033072T2 (de) 1999-10-28
CA2021309C (en) 2003-04-01
JPH03215745A (ja) 1991-09-20
DE69033072D1 (de) 1999-06-02
EP0409176A2 (de) 1991-01-23

Similar Documents

Publication Publication Date Title
ES2153030T3 (es) Procedimiento de analisis cuantitativo del colesterol.
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
BR9611461A (pt) Aparelho de coleta de amostras, kit para a detecçao de um analisado em uma amostra, uso do aparelho de coleta de amostra e do kit e processo para detectar um analisado em uma amostra.
WO1996007761A3 (en) Method for testing for mutations in dna from a patient sample
ATE152243T1 (de) Probentestträger und verfahren zur prüfung von okkultem blut im stuhl
WO2003001964A3 (en) Measurement testing of blood specimens
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
HK1092217A1 (en) Rapid test for glycated albumin
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
BR8302286A (pt) Aperfeicoamento em processo para determinacao da presenca de um analisador em uma amostra, aparelho de diagnostico inteiramente calibrado e kit para uso em um ensaio diagnostico
EP2251433A3 (de) Multichemie-Messvorrichtung und Teststreifen
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
PT1003458E (pt) Teste de funcao hepatica
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
ATE179522T1 (de) Verfahren und mittel zum nachweis von krankheitszuständen aus änderungen im östrogenstoffwechsel
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
ES2107528T3 (es) Ensayos de la actividad de la amilina.
DE69625239D1 (de) Verfahren zur krebsdetektion
DE50113202D1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
Moss et al. A semi-automatic method of measuring leucocyte movement
NO20016080L (no) Analyse
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE317454T1 (de) Verfahren zur aktivitätsbestimmung einer substanz mittels eines funktionellen in vitro tests
DINWOODIE et al. JOOSSENS, JVJ
NL7811903A (nl) Werkwijze voor het uitvoeren van een in vitro test ter diagnose van kwaadaardige tumoren, alsmede de voor deze werkwijze te gebruiken testplaat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties